Oriental Fortune Joins CICC in Biologics Therapy Play
03 Oct 2025
US$ 20.00
Oriental Fortune Capital was party to the near Rmb600 m (US$84.3 m) series C2 funding round of TJ Biopharma (Hangzhou)...
Related Publications
Subscribers’ Weekly for the week ending 10th Oct 2025...
Listen to Rest of Asia/Rest of the World Investments (Subscribers' Weekly 03 Oct 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.